Skip to main content
Metastatic Bladder CancerExercise and fitnessPainDigital healthBehavioralCancerBrain and nervesProcedureBehavioral

What this study is

The goal of this study is to evaluate the feasibility and preliminary efficacy of a combined acupuncture and exercise intervention for the management of chemotherapy-induced peripheral neuropathy (CIPN) in participants with bladder cancer receiving enfortumab vedotin (EV) and pembrolizumab (Pembro).

The names of the two study groups in this research study are:

  • Acupuncture + Virtual Exercise (AVE)
  • Virtual Exercise Only (VE)

What's being tested

  • Acupuncture

    Intervention · PROCEDURE

    Acupuncture treatment with licensed acupuncturist.

  • Exercise

    Intervention · BEHAVIORAL

    Virtually supervised, technology-based aerobic and resistance exercise program. Exercise bike and resistance bands will be provided to participants. Exercise sessions will be via HIPAA-compliant, teleconference platform Zoom.

Study details

Official title
Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy (ACE)
Sponsor
Dana-Farber Cancer Institute
Conditions
Metastatic Bladder Cancer · Peripheral Neuropathy · Advanced Urothelial Cancer · Metastatic Urothelial Cancer · Bladder Cancer · Urothelial Cancer
Enrolling
20 people
Starts
2026-09-03
Est. completion
2028-08
Design
Open-label, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗